This Book >>

  • 325pp. Published July 2017
  • Scientific Research Publishing, Inc.,USA.
  • Category: Medicine & Healthcare
  • ISBN: 978-1-61896-420-5
  • (Hardcover) USD 109.00
  • ISBN: 978-1-61896-419-9
  • (Paperback) USD 89.00
Authors/Editors Price: 40% off
Buy at: bookorder@scirp.org

Connect with SCIRP >>

Home > Books > Advances in Tumor Screening & Early Dete...
Advances in Tumor Screening & Early Detection
  • Description
  • Author(s) Information

Tumor screening aims to detect cancer before symptoms appear. This may involve blood tests, urine tests, other tests, or medical imaging. The benefits of screening in terms of cancer prevention, early detection and subsequent treatment must be weighed against any harms.

 

Universal screening, mass screening or population screening involves screening everyone, usually within a specific age group. Selective screening identifies people who are known to be at higher risk of developing cancer, such as people with a family history of cancer.

 

Screening can lead to false positive results and subsequent invasive procedures. Screening can also lead to false negative results, where an existing cancer is missed. Controversy arises when it is not clear if the benefits of screening outweigh the risks of the screening procedure itself, and any follow-up diagnostic tests and treatments.

Components of the Book:
  • Chapter 1
    Cascade Fumarate Hydratase mutation screening allows early detection of kidney tumour: a case report
  • Chapter 2
    Evaluation of the interval cancer rate and its determinants on the Girona health region’s early breast cancer detection program
  • Chapter 3
    Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs
  • Chapter 4
    Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain
  • Chapter 5
    Endoscopic tattooing of early colon carcinoma enhances detection of lymph nodes most prone to harbor tumor burden
  • Chapter 6
    Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening
  • Chapter 7
    Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening study
  • Chapter 8
    Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer
  • Chapter 9
    An evaluation of SOX2 and hTERC gene amplifications as screening markers in oral and oropharyngeal squamous cell carcinomas
  • Chapter 10
    Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study
Readership: Students, academics, teachers and other people attending or interested in Tumor Screening and/or Early Detection.
comments powered by Disqus